Takeda (Canada)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 4 of 4 papers

  • Open Access
  • Research Article

Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study

  • Jan 21, 2026
  • Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
  • Stephen D Betschel +7
  • Open Access
  • Research Article

P0588 Efficacy and health-related quality of life associated with second-line vedolizumab after one prior first-line anti-tumour necrosis factor treatment in patients with active ulcerative colitis: A meta-analysis of the GEMINI-1 and VISIBLE-1 trials

  • Jan 22, 2025
  • Journal of Crohn's and Colitis
  • R Atreya +6
  • Open Access
  • Research Article
  • Citations8

Disruption of Pharmacotherapy During the Transition from Adolescence to Early Adulthood in Patients with Attention-Deficit/Hyperactivity Disorder: A Claims Database Analysis Across the USA.

  • Apr 15, 2021
  • CNS Drugs
  • Sepehr Farahbakhshian +7
  • Open Access
  • Research Article
  • Citations8

P573 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study

  • Jan 25, 2019
  • Journal of Crohn's and Colitis
  • A Yarur +13
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.